Naoki Morita

Naoki Morita


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2016 in Marine Drugs
Verified
Journal Article
Open access
PDF file
KYKiyohito Yoshida
Kiyohito Yoshida
MHMikako Hashimoto
Mikako Hashimoto
RHRyuji Hori
Ryuji Hori
TATakumi Adachi
Takumi Adachi
HOHidetoshi Okuyama
Hidetoshi Okuyama
NMNaoki Morita
Naoki Morita
The nutritional and pharmaceutical values of long-chain polyunsaturated fatty acids (LC-PUFAs) such as arachidonic, eicosapentaenoic and docosahexaenoic acids have been well recognized. These LC-PUFAs are physiologically important compounds in bacteria and eukaryotes. Although little is known about the biosynthetic mechanisms and functions of LC-PUFAs in bacteria compared to those in higher organisms, a combination of genetic, bioinformatic, and molecular biological approaches to LC-PUFA-producing bacteria and some eukaryotes have revealed the notably diverse organization of the pfa genes encoding a polyunsaturated fatty acid synthase complex (PUFA synthase), the LC-PUFA biosynthetic processes, and tertiary structures of the domains of this enzyme. In bacteria, LC-PUFAs appear to take part in specific functions facilitating individual membrane proteins rather than in the adjustment of the physical fluidity of the whole cell membrane. Very long chain polyunsaturated hydrocarbons (LC-HCs) such as hentriacontanonaene are considered to be closely related to LC-PUFAs in their biosynthesis and function. The possible role of LC-HCs in strictly anaerobic bacteria under aerobic and anaerobic environments and the evolutionary relationships of anaerobic and aerobic bacteria carrying pfa-like genes are also discussed.

1 March 2005 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
NMNaoki Morita
Naoki Morita
TNTakanori Nishida
Takanori Nishida
MTMika Tanaka
Mika Tanaka
YYYutaka Yano
Yutaka Yano
HOHidetoshi Okuyama
Hidetoshi Okuyama

1 March 2019 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
SKShinji Kato
Shinji Kato
HTHaruhi Tobe
Haruhi Tobe
HMHiroki Matsubara
Hiroki Matsubara
MSMariko Sawada
Mariko Sawada
YSYasuko Sasaki
Yasuko Sasaki
AYAtsushi Yokota
Atsushi Yokota

2 November 2019 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Open access
PDF file
SHSanae Haga
Sanae Haga
YMYi Min
Yi Min
HYHikari Yamaki
Hikari Yamaki
SJShigeki Jin
Shigeki Jin
TSTetsuya Sogon
Tetsuya Sogon
Michitaka OzakiMichitaka Ozaki
Michitaka Ozaki
Bilberry has been reported to have anti-oxidant and anti-inflammatory properties. We studied the effect of bilberry (Vaccinium myrtillus L.) fruits extracts (BEs) on the pathogenesis caused by lipid accumulation in fatty liver and non-alcoholic steatohepatitis (NASH). 5 μg/ml of BEs was enough to suppress lipid accumulation in the fatty liver model of the mouse hepatic AML12 cells. BEs increased cell viability and anti-oxidant capacity, presumably by activating (phosphorylating) Akt/STAT3 and inducing MnSOD/catalase. BEs also significantly reduced Rubicon and induced p62/SQSTM1, possibly contributing to reduce cellular lipids (lipophagy). When the mice were fed supplemented with BEs (5% or 10%, w/w), hepatic steatosis, injury, and hypercholesterolemia/hyperglycemia were significantly improved. Furthermore, histological and cytokine studies indicated that BEs possibly suppress hepatic inflammation (hepatitis) and fibrosis. Therefore, BEs improved liver steatosis and injury, and potentially suppress fibrosis by suppressing inflammatory response, which therefore may prevent the progression of fatty liver to NASH.

2 April 2013 in AMB Express
Verified
Journal Article
Open access
PDF file
SSShun Sato
Shun Sato
NMNaoki Morita
Naoki Morita
DKDai Kitamoto
Dai Kitamoto
TYToshiharu Yakushi
Toshiharu Yakushi
KMKazunobu Matsushita
Kazunobu Matsushita
HHHiroshi Habe
Hiroshi Habe
To enhance the value-added use of methanol-containing raw glycerol derived from biodiesel fuel production, the effect of methanol supplementation on glyceric acid (GA) production byGluconobacterspp. was investigated. We first conducted fed-batch fermentation withGluconobacter frateuriiNBRC103465 using raw glycerol as a feeding solution. GA productivity decreased with increasing dihydroxyacetone (DHA) formation when the raw glycerol contained methanol. The results of this experiment and comparative experiments using a synthetic solution modeled after the raw glycerol indicate that the presence of methanol caused a change in the concentrations of GA and DHA, two glycerol derivatives produced during fermentation. OtherGluconobacterspp. also decreased GA production in the presence of 1% (v/v) methanol. In addition, purified membrane-bound alcohol dehydrogenase (mADH) fromGluconobacter oxydans, which is a key enzyme in GA production, showed a decrease in dehydrogenase activity toward glycerol as the methanol concentration increased. These results strongly suggest that the observed decrease in GA production byGluconobacterspp. resulted from the methanol-induced inhibition of mADH-mediated glycerol oxidation.

1 July 2005 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
NMNaoki Morita
Naoki Morita
NINobutoshi Ichise
Nobutoshi Ichise
IYIsao Yumoto
Isao Yumoto
YYYutaka Yano
Yutaka Yano
SOSatoru Ohgiya
Satoru Ohgiya
HOHidetoshi Okuyama
Hidetoshi Okuyama